Literature DB >> 21752468

Alternately binding probe competitive PCR as a simple, cost-effective, and accurate quantification method for JAK2V617F allele burden in myeloproliferative neoplasms.

Soji Morishita1, Norio Komatsu, Keita Kirito, Aya H Koda, Yuji Sekiguchi, Satoshi Tsuneda, Naohiro Noda.   

Abstract

We developed a simple, cost-effective, and accurate JAK2 allele burden quantification method named alternately binding probe competitive PCR (ABC-PCR). ABC-PCR can be performed to quantify target JAK2 allele burdens in a single reaction. The throughput and running cost of ABC-PCR are markedly improved compared with those of allele-specific quantitative PCR (AS-qPCR). The quantification of samples with known JAK2 allele burdens revealed that ABC-PCR had a small assay-to-assay variation. The JAK2 allele burdens in the patients with myeloproliferative neoplasms measured by ABC-PCR and AS-qPCR showed a good fitting. ABC-PCR would be a powerful tool for quantifying target JAK2 allele burdens. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21752468     DOI: 10.1016/j.leukres.2011.06.016

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  6 in total

1.  JAK2V617F mutation status and allele burden in classical Ph-negative myeloproliferative neoplasms in Japan.

Authors:  Yoko Edahiro; Soji Morishita; Kochi Takahashi; Yumi Hironaka; Yuriko Yahata; Yoshitaka Sunami; Shuichi Shirane; Miyuki Tsutsui; Masaaki Noguchi; Michiaki Koike; Kiyotoshi Imai; Keita Kirito; Naohiro Noda; Yuji Sekiguchi; Satoshi Tsuneda; Akimichi Ohsaka; Marito Araki; Norio Komatsu
Journal:  Int J Hematol       Date:  2014-03-28       Impact factor: 2.490

2.  Mutational subtypes of JAK2 and CALR correlate with different clinical features in Japanese patients with myeloproliferative neoplasms.

Authors:  Kyohei Misawa; Hajime Yasuda; Marito Araki; Tomonori Ochiai; Soji Morishita; Shuichi Shirane; Yoko Edahiro; Akihiko Gotoh; Akimichi Ohsaka; Norio Komatsu
Journal:  Int J Hematol       Date:  2018-02-20       Impact factor: 2.490

3.  Consequences of the JAK2V617F allele burden for the prediction of transformation into myelofibrosis from polycythemia vera and essential thrombocythemia.

Authors:  Shuichi Shirane; Marito Araki; Soji Morishita; Yoko Edahiro; Yoshitaka Sunami; Yumi Hironaka; Masaaki Noguchi; Michiaki Koike; Eriko Sato; Akimichi Ohsaka; Norio Komatsu
Journal:  Int J Hematol       Date:  2014-12-19       Impact factor: 2.490

4.  Validation of standards for quantitative assessment of JAK2 c.1849G>T (p.V617F) allele burden analysis in clinical samples.

Authors:  Paul Collier; Keyur Patel; Paul Waeltz; Mark Rupar; Rajyalakshmi Luthra; Phillip C C Liu; Gregory Hollis; Reid Huber; Srdan Verstovsek; Timothy C Burn
Journal:  Genet Test Mol Biomarkers       Date:  2013-03-28

5.  Detection of MPLW515L/K mutations and determination of allele frequencies with a single-tube PCR assay.

Authors:  Hiraku Takei; Soji Morishita; Marito Araki; Yoko Edahiro; Yoshitaka Sunami; Yumi Hironaka; Naohiro Noda; Yuji Sekiguchi; Satoshi Tsuneda; Akimichi Ohsaka; Norio Komatsu
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

6.  Melting curve analysis after T allele enrichment (MelcaTle) as a highly sensitive and reliable method for detecting the JAK2V617F mutation.

Authors:  Soji Morishita; Kochi Takahashi; Marito Araki; Yumi Hironaka; Yoshitaka Sunami; Yoko Edahiro; Miyuki Tsutsui; Akimichi Ohsaka; Satoshi Tsuneda; Norio Komatsu
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.